Hearing Loss Trial, Recruiting (NCT06051006)

Hearing Loss Trial, Recruiting NCT06051006 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06051006 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 8 and 17 years old and have had a cochlear implant for at least 1 year
You are currently being seen and followed at Hôpital Necker-Enfants Malades
You mainly communicate by speaking French out loud
Your hearing test results with the cochlear implant show a certain level of hearing loss (40 dB or more) (confirm with trial site)
Your ear pressure test (tympanogram) comes back normal
Your ability to hear and understand speech at a quiet volume meets a specific level set by the trial (confirm with trial site)
You (and your parent or guardian) are willing to give permission to take part in the study

Who may not be able to join:

You have been diagnosed with a serious neurological condition before joining the trial
You have a significant cognitive (thinking or learning) difficulty, psychiatric condition, or severe developmental delay at the time of joining
Your family does not understand spoken French
You are covered by AME (a specific French government healthcare program for certain individuals) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Melissa MacAskill, Assistance Publique - Hôpitaux de Paris

Phone: 0187892914

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06051006

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 0187892914

More information: https://clinicaltrials.gov/study/NCT06051006

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 8 and 17 years old and have had a cochlear implant for at least 1 year
You are currently being seen and followed at Hôpital Necker-Enfants Malades
You mainly communicate by speaking French out loud
Your hearing test results with the cochlear implant show a certain level of hearing loss (40 dB or more) (confirm with trial site)
Your ear pressure test (tympanogram) comes back normal
Your ability to hear and understand speech at a quiet volume meets a specific level set by the trial (confirm with trial site)
You (and your parent or guardian) are willing to give permission to take part in the study

Who may not be able to join:

You have been diagnosed with a serious neurological condition before joining the trial
You have a significant cognitive (thinking or learning) difficulty, psychiatric condition, or severe developmental delay at the time of joining
Your family does not understand spoken French
You are covered by AME (a specific French government healthcare program for certain individuals) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

7 December 2023

Est. completion

7 January 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The relationship between the patient's current upper stimulation level (C-subjective) and the measured eSRT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov